J Biol Chem, Vol. 274, Issue 39, 27666-27673, September 24, 1999
New Human Immunodeficiency Virus, Type 1 Reverse Transcriptase
(HIV-1 RT) Mutants with Increased Fidelity of DNA Synthesis
ACCURACY, TEMPLATE BINDING, AND PROCESSIVITY*
Baek
Kim
§,
Jennifer C.
Ayran¶,
Sarah G.
Sagar¶,
Elinor T.
Adman
,
Shannon M.
Fuller
,
Nancy H.
Tran
, and
Jeffrey
Horrigan
From the
Department of Microbiology and Immunology,
University of Rochester, Rochester, New York 14642, the
¶ Departments of Pathology, and
Biological Structure,
University of Washington, Seattle, Washington 98195
 |
ABSTRACT |
Infidelity of DNA synthesis by human
immunodeficiency virus, type 1 reverse transcriptase (HIV-1 RT) is a
presumptive determinant of HIV-1 hypervariability and is incompletely
understood at the mechanistic and structural levels. Amino acid
substitution at only three residues, including Asp-76 (Kim, B.,
Hathaway, T. R., and Loeb, L. A. (1996)
Biochemistry 37, 5831-5839), is known to increase
fidelity. We report here that substitution at Arg-78 can also increase
accuracy. Mutant R78A RT showed reduced primer extension in
misincorporation assays lacking a complementary dNTP and exhibited a
9-fold decrease in mutation frequency in the M13mp2 lacZ
forward mutation assay. Previous structural studies indicate that
Arg-78 and Asp-76 lie in a region that interacts with template nucleotides. Interestingly, R78A RT exhibited 6- to 8-fold decreases in
binding affinity (Kd) for RNA and DNA templates
relative to wild type RT. In contrast, D76V RT, which also increases
fidelity (Kim et al., 1996), showed a 6- to 7-fold
increased affinity. The processivity of R78A RT on both RNA and DNA
templates was substantially reduced relative to wild type RT, whereas
the processivity of D76V RT was increased. We discuss relationships of
fidelity, template binding, and processivity in these and other HIV RT mutants.
 |
INTRODUCTION |
Genomic hypervariability is a defense device that allows human
immunodeficiency virus, type 1 (HIV-1)1 to escape from
selection pressure such as that imposed by the host immune system or
drug therapies. Hypervariation of HIV-1 genomes can be achieved by at
least three unique viral replication processes. First, mutations can be
synthesized by the virally encoded DNA polymerase, HIV-1 reverse
transcriptase (RT) (1, 2). HIV-1 RT is the most error prone of all
known DNA polymerases (3-7). Second, mutations produced by HIV-1 RT
can be amplified by recombination, which has been observed in virions
containing heterogeneous diploid genomes (8). It has been suggested
that the occurrence of homologous recombination during viral
replication is related to the processivity and strand transfer activity
of HIV-1 RT (9, 10). Finally, constant, massive replication amplifies
the complexity of the viral population (11).
The structural basis of HIV-1 RT infidelity remains to be fully
elucidated. Lack of a 3'-5' proofreading exonuclease activity is a
presumptive factor (4), but it cannot be the only determinant, because
other retroviral RTs that lack a proofreading exonuclease, such as
murine leukemia virus RT and AMV RT, have 10- to 18-fold higher
fidelity (3). Our knowledge of the structure-function relationships
governing the accuracy of other DNA polymerases rests heavily on the
analysis of mutants (12, 13); the classic mutants of
Escherichia coli DNA polymerase I are important
examples (14). Currently available mutants of HIV-1 RT are mostly
drug-resistant variants isolated from patients and cell culture
systems. Interestingly, it has been reported that drug resistance
mutations at Met-184 (M184V, M184I) and Glu-89 (E89G) confer increased
fidelity (15-18). Biochemical studies suggest that these mutations
affect accuracy by altering interactions with either the incoming dNTP
(M184V and M184I) or with the penultimate nucleotide of the
double-stranded template (E89G). Notably, these drug-resistant
mutations permit continued viral evolution and escape from selective
pressure, suggesting that the changes in fidelity may be rather
moderate. Other interactions of HIV-1 RT with its substrates also
affect accuracy. Thus, mutations (e.g. G262A and W266A) in
the thumb subdomain that interact with the primer have been shown to
affect the frequency of frameshift mutations, presumably because of
template-primer slippage; these mutations also alter processivity (19,
20).
To better understand the structural and mechanistic basis of HIV-1 RT
infidelity, we have undertaken a systematic approach to the study of
mutants. To obtain novel fidelity mutations, we employ both genetic and
biochemical methods (21). We initially select for catalytically active
mutants among a large, randomly mutated RT population by using a
genetic complementation system (22, 23). Mutants with altered accuracy
are then identified by screening in a primer extension assay. In this
way, we obtain numerous catalytically robust fidelity mutants for
detailed biochemical, kinetic, and structural analysis. Other amino
acid substitutions of interest, suggested by these genetically selected
variants, can then be synthesized by site-directed mutagenesis.
Substitutions that confer increased accuracy are of particular
relevance because they identify amino acid side chains that are
responsible for mutation synthesis by the wild type enzyme. Among
genetically selected variants with increased DNA synthetic accuracy (we
call them "hi-fi" mutants), we have previously described D76V,
which exhibited a 9-fold increase in fidelity in a lacZ
forward mutation assay, and up to 14-fold increases in the accuracy of
nucleotide insertion. Structural studies indicate that Asp-76 interacts
with the template nucleotide that base pairs with the incoming dNTP (21, 24). Presumably, in wild type RT, interaction of Asp-76 with the
template may promote mispairing with the incoming nucleotide, whereas
other residues, such as valine, reduce or abolish this mutagenic
interaction. This presumption is consonant with the findings for
Glu-89, which also interacts with the template. Glu-89 contacts the
template nucleotide that pairs with the penultimate primer nucleotide
(18), and mutation, at this site too, can increase fidelity. The mutant
E89G exhibits enhanced fidelity (18), higher processivity, and a
decreased dissociation constant from a RT·template·primer complex
(25). Taken together, these observations are consistent with our
premise, based on the D76V mutation, that amino acid residues involved
in interactions with the template can play an important role in HIV-1
RT infidelity (21).
Our previous structural modeling (21), undertaken in connection with
the D76V mutant, suggested that Arg-78 interacts with the template
nucleotide that base pairs with the nucleotide at the 3' primer
terminus. In view of this putative interaction of Arg-78 with the
template and the possible effect on fidelity, we decided to generate
and examine the accuracy of mutants with amino substitutions at this
position. Recently, Huang et al. (25) reported the structure
of a catalytic complex of HIV RT with a DNA template-primer and a dNTP.
Although generally similar to our model, the x-ray structure shows that
Arg-78 interacts directly with Asp-76 and indirectly with the template
nucleotide base paired to the incoming dNTP. This template nucleotide
lies between the nucleotide that interacts with both Asp-76 and base
pairs with the incoming dNTP and the nucleotide that interacts with
both Glu-89 and base pairs to the penultimate primer nucleotide. We report here new HIV-1 RT variants with mutations at Arg-78 that exhibit
increased fidelity and altered interactions with DNA and RNA templates.
We interpret available evidence to indicate that interactions of Arg-78
with both Asp-76 and the template nucleotide base pairing with the
incoming dNTP play important roles in HIV-1 RT infidelity. We suggest
that interactions of these two residues with the template nucleotide
may promote the formation of a mutagenic DNA polymerization active
site, thereby contributing to a high rate of mutation during viral replication.
 |
EXPERIMENTAL PROCEDURES |
Strains and Plasmids--
E. coli NM522 (Stratagene)
was used for construction of plasmids, and BL21 (Novagen) was used for
over-expression of HIV-1 RT. pBK33 is pHis/NdeI (from Dr. A. Hizi) encoding full-length wild type p66 HIV-1 RT fused at the N
terminus to six histidine residues (22). pBK44 is a pET28a (Novagen)
derivative expressing wild type p51 HIV-1-1 RT fused at the N terminus
to six histidine residues. pBK77 and pBK78 are pHis/NdeI
constructs for expression of His-tagged p66 of wild type SIV RT that
was derived from pSIVMNE170 (from Dr. J. T. Kimata,
Southwest Foundation for Biomedical Research, TX) and the R78A SIV RT
mutant, respectively.
Construction of Arg-78 Mutants of HIV-1 and SIV RTs--
Amino
acid substitutions at Arg-78 of HIV-1 RT were generated by using
PCR-based site-directed mutagenesis with Arg-78 primers (5'-CTTATTGAGCTCTCTGAANNNTACTAATTTTCTCCATTTAG-3') that contained 100%
random nucleotides (designated "N") at the positions encoding residue 78. The products of PCR amplification with Arg-78 primer and
SD-RT primer (5'-GAAGATCTAAGCTTAGGAGGTTGTCCCATATGCCCATTAGTCC-3'), which
hybridizes to the N-terminal sequence of HIV-1 RT and the NdeI site, were inserted into pBK33 for p66 RT after
digestion with BsrGI and SacI. A 126-base pair
region between BsrGI and SacI of the plasmids
expressing Asp-76 mutants was sequenced to confirm mutations at
position 78. After sequencing the 126-base pair fragment inserts to
verify the mutations at position 78 of RT, the 126-base pair fragments
prepared from pBK33 of individual mutation constructs were cloned
to pBK44 for p51 RT mutant proteins. The plasmids expressing His-tagged
Arg-78 SIV RT mutants were constructed by PCR-based site-directed
mutagenesis using two pieces of PCR products. One is the PCR product
encoding the N-T part of SIV RT and an Arg-78 mutation that was
amplified with SD-SIV RT
(5'-TTTTTTAAGCTTGAAGGAGATATACATATGCCCATAGCTAAGGTAGAGCC-3') and an
Arg-78 reverse primer (5'-TTT TTTGAGCTCNNNAAAATCTATCAGTATTCTCC-3') containing 100% randomized sequences at position Arg-78 (designated N)
and a SacI site near position 79 of SIV RT. The other is the PCR product encoding the C-T part of the SIV RT that was amplified with
a SIV-SacI forward primer (5'-TTTTTTGAGCTCAATAAGGTCACTCAG GAC-3') containing a SacI site at position 79 and a SIV C-T
primer (5'-TTTTTTGGATCCGTCGACTTAAACTTGTCTAATCCCTTG-3'). After
digestion of N-T PCR by NdeI/SacI and C-T PCR by
SacI/BamHI, these two digested DNAs were ligated
to pHis/NdeI-digested NdeI and BamHI.
For the expression plasmid for wild type SIV RT, the wild type SIV RT gene amplified from pSIVMNE170 by using SD SIV RT and SIV
C-T primers (see the SIV C-T primer sequence above) was cloned to the
pHis/NdeI plasmid after digestion with NdeI and
BamHI. All SIV RT genes in these constructed expression
plasmids were sequenced by ABI system.
Purification of HIV-1 RT and SIV RT--
Procedures for
purification of the hexahistidine-tagged p66 and p51 monomers of HIV-1
RT by Ni2+ chelation chromatography have been described;
equi-molar amounts of separately purified p66 and p51 of HIV-1 RT were
mixed prior to dialysis to form p66/p51 heterodimers (22, 23).
Reconstructed p66/p51 heterodimers of wild type and Asp-76 mutant
proteins were used for the fidelity assays described below. Amounts of
purified monomers were estimated in the Bradford assay (Bio-Rad) with a bovine serum albumin standard; all preparations were of >95% purity, estimated by visual inspection of Coomassie Blue-stained
SDS-polyacrylamide gels. DNA- and RNA-dependent DNA
polymerase activities were determined as described (22); the assays
employed a gapped salmon sperm DNA template-primer, poly(rA)/oligo(dT)
(Amersham Pharmacia Biotech), or an RNA template encoding the HIV-1 RT
gene. Preparation of the RNA template is described below (see primer
extension assay). We previously found that a 6 His tag of purified
HIV-1 RT proteins does not affect DNA polymerase activity and
sensitivity to a nucleotide analog (22). We also found both p66/p51
heterodimers and p66/p66 homodimers of wild type and mutant HIV-1 RT
proteins showed the same level of misinsertion in four different types
of the primer extension reactions described below. The SIV RT p66
fragment was purified by following the purification protocol
established for HIV-1 RT. With this protocol, we were able to purify 2 mg of SIV RT proteins with greater than 95% purity from a 1-liter culture.
Primer Extension Assay with DNA or RNA Templates--
Procedures
(22) were modified from those of Preston et al. (7).
The deoxyoligonucleotide template-primer was prepared by
annealing a 63-mer
(5'-TAATACGACTCACTATAGGGAGGAAGCTTGGCTGCAGAATATTGCTAGCGGGAATTCGGCGCG-3') to a 17-mer (5'-CGCGCCGAATTCCCGCT-3')
32P-labeled at the 5'-end with T4 polynucleotide
kinase (template:primer, 2.5:1). Assay mixtures (20 µl) contained 10 nM template-primer, 5-50 nM HIV-1 RT or SIV RT
as specified in figure legends, 3 or 4 dNTPs (250 µM
each), 25 mM Tris-HCl (pH 8.0), 100 mM KCl, 2 mM dithiothreitol, 5 mM MgCl2, and
0.1 mg/ml bovine serum albumin. Reactions were incubated at 37 °C
for 5 min and terminated by the addition of 5 µl of 40 mM
EDTA, 99% formamide. Reaction products were immediately denatured by
incubating at 95 °C for 3 min and analyzed by electrophoresis in
14% urea-polyacrylamide gels. The 1.6-kilonucleotide RNA template used
in this assay contains the coding sequence of the HIV-1 RT gene and was
synthesized by T7 RNA polymerase-catalyzed transcription of pBK8 (22),
which encodes the HIV-1 RT gene between the HindIII and
EcoRI sites of pBluescript (Stratagene). The transcribed RNA
was purified by ethanol precipitation and annealed to a
32P-labeled 21-mer (3305 RT primer (22)) complementary to
nucleotides encoding amino acids 239-246 of HIV-1 RT. Reaction
conditions were otherwise the same as described above. Extension
products were resolved in 10% denaturing gels.
M13mp2 lacZ Forward Mutation Assay--
The mutation frequencies
for wild type and mutant HIV-1 RT were measured essentially as
described previously (27). M13mp2 DNA containing a 361-nucleotide
single-stranded gap was prepared as specified (27). Gapped DNA (1 µg)
was incubated with RT (200 nM) at 37 °C for 10 min under
the conditions described below for the misinsertion assays. The
extended gapped DNAs by RT proteins were analyzed by 0.7% agarose for
checking the production of double strand M13 DNA with filled gaps
(27). The extended gapped DNAs were transformed to MC1016 cells, and
the transformed cells were plated to M9 plates containing
5-bromo-4-chloro-3-indolyl
-D-galactopyranoside (X-gal) and isopropyl-1-thio-
-D-galactopyranoside with
CSH50 lawn cells. The mutation frequency was determined as the ratio of
mutant (pale blue and white) plaques to mutant plus wild type (dark
blue) plaques as described (27). The lacZa genes encoded in
the M13 phage DNA prepared from mutant plaques were sequenced as
described (27).
Measurment of Kd to DNA Template--
Binding constants
(Kd) of HIV-1 RT proteins to the 63-mer DNA template
annealed to the 17-mer primer, and HIV-1 RNA template encoding the 1.7 kilonucleotide RT gene annealed to the 3305 template were measured as
described (28, 29). HIV-1 RT proteins (20 nM) were
preincubated with various concentrations of the template·primer
complexes (T·P) used in the misinsertion assay (1, 2.5, 5, 10, 15, 20, 30, 40, 60, 80, and 100 nM) for 3 min at 37 °C. Each
of these T·P concentrations contains 1 nM 32P-labeled template-primer. The extension reactions (total
20 µl) were initiated by adding a mixture of 0.5 mM dNTPs
with 5 mM MgCl2 (final concentration) and a
poly(rA)/oligo(dT) trap (4 µg/20µl), and after a 3-min incubation
at 37 °C, the reactions were terminated by adding 4 µl of stop
solution (90% formamide, 5 mM EDTA, 0.1% xylene cyanol,
and 0.1% bromphenol blue). The terminated reactions were immediately
incubated at 95 °C for 5 min. Under this reaction condition, RT
extended the primers only once during the incubation. To confirm this
single round of extension, two control reactions for each T·P
concentration were performed. First, RT proteins were added to the
mixture of the T·P of each concentration, poly(rA)/oligo(dT) trap and
dNTPs, and the reactions continued for 3 min at 37 °C. In this
condition the primer was not able to be extended because all RT
molecules were successfully trapped by excess molar concentrations (4 µg/20 µl) of a poly(rA)/oligo(dT) trap. Second, the reactions without the trap showed the larger amount of the primer extended because of multiple rounds of replication. These two control
experiments guaranteed the single round of extension reaction under our
reaction condition. The extension reactions at different T·P
concentrations were analyzed by 14 and 10% urea-polyacrylamide gel
electrophoresis for DNA and RNA templates, respectively. The amounts of
the extended and unextended primers at each T·P concentration were
determined by phosphoimager analysis of the gel. The data were fitted
to the equation described previously (28, 29; see Eq. 1 below), and the
Kd values for wild type, R78A, and D76V RT proteins were determined.
|
(Eq. 1)
|
In Equation 1, E
T·P,
Kd, Et, and T·P indicate
productive RT-template concentration, equilibrium dissociation constant
for RT-template binding, total enzyme concentration, and total
template·primer concentration, respectively.
Processivity Assay--
Reaction condition for measuring
processivity also requires a single round of primer extension. The
reaction condition for processivity assay was modified from the one
used for Kd measurement described above. Two
concentrations of three RT proteins, wild type (10 and 20 nM), D76V (2.5 and 5 nM), and R78A (40 and 80 nM) HIV-1 RT proteins were used for RNA and DNA templates. RT proteins were preincubated with either 10 nM poly(rA)
(average size, 260 nt, Amersham Pharmacia Biotech) annealed to the
32P-labeled 20-mer oligo(dT) or the M13mp18 single strand
DNA (+) annealed to the 32P-labeled 24-mer forward primer
(Stratagene) for 3 min at 37 °C. The extension reactions were
initiated by adding the trap mixture containing dNTPs (0.5 mM with final concentration 5 mM
MgCl2), poly(rA)/oligo(dT) (4 µg/20 µl), and heparin
(10 µg/20 µl). The extension reactions were terminated by 2 µl of
stop solution after a 3-min incubation at 37 °C. Under this
condition, the primer was extended only once during the incubation as
confirmed by the same two control reactions with or without the trap
(see Fig. 4). The terminated processivity reaction and control
reactions were analyzed by 10% urea-polyacrylamide gel electrophoresis
after a 3-min heat inactivation.
 |
RESULTS |
Construction and Purification of Arg-78 Mutants of HIV-1
RT--
Eleven different amino acid substitutions at Arg-78 of HIV-1
RT were generated in both the p66 and p51 subunits by using PCR-based site-directed mutagenesis. The hexahistidine-tagged, wild type and
mutant monomers were overexpressed in E. coli and purified by Ni2+ affinity chromatography. Heterodimers, formed by
dialyzing equimolar quantities of separately purified p66 and p51
monomers, were used for the work described below. Specific activities
of 8 of the 11 Arg-78 mutants (R78A, R78S, R78L, R78I, R78T, R78V,
R78C, and R78G), measured on activated calf thymus DNA, ranged from 25 to 35% of the wild type. The remaining three mutants (R78Y, R78E, and
R78P) exhibited much lower specific activities ranging from 5 to 10%
of the wild type. In accord, specific activities of the Arg-78 mutants
measured by using poly(rA) template annealed to oligo(dT) ranged at
similar levels of the DNA-dependent DNA polymerase activities.
Misinsertion Assay of R78A HIV-1 RT Mutants with DNA and RNA
Templates--
We first employed misinsertion assays to compare the
misincorporation capability of wild type and R78A mutant HIV-1 RTs.
This assay is a primer extension assay that monitors misinsertion by utilizing a synthetic DNA or RNA template-primer and biased dNTP pools
containing only three kinds of dNTPs. A gel-displaying extension of the
17-mer primer annealed to a 63-mer DNA template by two quantities (4×
and 1×) of wild type, and R78A HIV-1 heterodimer RT is shown in Fig.
1A. In this assay, the higher
efficiency of primer extension will reflect the lower fidelity of the
HIV-1 RT protein assayed. The specific activity of the purified R78A mutant, as determined with heterogeneous DNA and RNA templates, was
approximately 30% of that of wild type RT. As shown in Fig. 1A, loaded with reactions containing all four dNTPs, the
wild type and R78A mutant heterodimers catalyzed approximately the same
amount of synthesis leading to fully extended primers. When incubated
with mixtures of only 3 dNTPs (Fig. 1, B,
dTTP;
C,
dCTP; D,
dGTP; E,
dATP), wild
type HIV-1 RT catalyzed substantial extension past nucleotides for
which a complementary dNTP was deleted (see the sites with an
asterisk in Fig. 1) indicating utilization of incorrect
nucleotides. On the other hand, the R78A mutant catalyzed less
synthesis and shorter extension than the wild type enzyme in reactions
with three dNTPs, indicative of higher replicational fidelity (Fig. 1,
B-E). Interestingly, the R78A RT showed a larger reduction
of the primer extension in the reactions with
TTP (B) and
dCTP (C) than in the reactions with
dGTP (D)
and
dATP (E).

View larger version (83K):
[in this window]
[in a new window]
|
Fig. 1.
Misinsertion assay of wild type and R78A
HIV-1 RT mutant proteins with DNA template. The
32P-labeled 17-mer primer (arrow) annealed to a
63-mer DNA template (5 nM) was extended by two different
concentrations (4× and 1×) of wild type (40 and 10 nM)
and R78A (75 and 25 nM) HIV-1 RT proteins at 37 °C for 5 min as seen in the extension reactions with all four dNTPs
(A). The extension reactions were also performed in the
presence of only 3 complementary dNTPs. B, minus TTP;
C, minus dCTP; D, minus dGTP; E, minus
dATP. The extension reactions were analyzed by 14% denaturing gel
electrophoresis. The DNA sequence of the first 26 nucleotides of the
extended part of the primer is shown in A. The sites with an
asterisk indicate the stop sites where the deleted dNTPs
would be incorporated in the reactions with only three dNTPs. In this
assay, the higher efficiency of elongation of terminated primer with
only three nucleotides will reflect the lower fidelity of the HIV-1 RT
protein assayed. WT, wild type.
|
|
Next, we performed the misinsertion assay with an RNA template encoding
the positive strand of the HIV-1 RT gene sequence. In this reaction,
like the first round of replication of HIV-1, RT proteins produce a
negative strand of viral DNA encoding the RT regions where most of the
RT drug-resistant mutations have been identified. We also employed AMV
RT as a high fidelity control RT. In the presence of all dNTPs, wild
type HIV-1 RT, R78A HIV-1 RT, and AMV RT proteins extended the primer
up to 250 nt. Two equal quantities of RNA-dependent DNA
polymerase activity of three RT proteins showing the extension of the
same 10 and 20% of total primer were determined by the reactions with
all dNTPs (Fig. 2A). As shown
in Fig. 2, B
TTP; C,
dGTP; D,
dCTP; and E,
dATP, AMV RT showed less extended primer
than wild type HIV-1 RT in the presence of only three dNTPs, confirming
that AMV RT has a higher replicational accuracy than wild type HIV-1 RT
(3). AMV RT showed a larger reduction of the primer extension in the reactions with
TTP (B) and
dATP (E) than the
reactions with
dGTP (C) and
dCTP (D). As seen
in Fig. 2, B-E, the R78A mutant HIV-1 RT showed an even
lower level of extended primer than AMV RT in the presence of three
dNTPs. This result indicates that R78A HIV-1 RT could have enhanced
fidelity. Interestingly, unlike AMV RT, R78A showed a larger reduction
of the primer extension in the reactions with
dGTP (C) as
well as the reactions with
TTP (B) and
dATP
(E).

View larger version (77K):
[in this window]
[in a new window]
|
Fig. 2.
Misinsertion assay of wild type HIV-1 RT,
R78A HIV-1 RT mutant, and AMV RT with RNA template. The
32P-labeled 21-mer 3305 primer (arrow) annealed
to a 1.7 kilonucleotide long RNA template encoding a positive strand of
HIV-1 RT sequence was extended by two different concentrations (2× and
1×) of wild type HIV-1 RT (10 and 5 nM), R78A (30 and 15 nM), HIV-1 RT and AMV RT (0.1 and 0.05 units) showing equal
RNA-dependent DNA polymerase activities at 37 °C for 5 min as seen in the extension reactions with all 4 dNTPs (A).
The extension reactions were also performed in the presence of only
three complementary dNTPs. B, minus TTP; C, minus
dGTP; D, minus dCTP; E, minus dATP. The extension
reactions were analyzed by 10% denaturing gel electrophoresis. The
first 14 nucleotide HIV-1 sequences of the extended part of the primer
are shown in A. The sites with an asterisk
indicate the stop sites where the deleted dNTPs would be incorporated
in the reactions with only three dNTPs. WT, wild type.
|
|
Like the R78A mutant, the Arg-78 HIV-1 RT mutants (R78S, R78L, R78I,
R78T, R78V, R78C, and R78G) with high activity showed reduced levels of
primer extension in the presence of only three dNTPs (data not shown).
However, we could not determine the fidelity of some mutants (R78Y,
R78E, and R78P) because of their largely reduced DNA polymerase activities.
LacZ Forward Mutation Assay of R78A HIV-1 RT Mutants--
This
method has been used to determine mutation frequencies of DNA
polymerases (27). Mutations generated when DNA polymerase copies the
gapped region of the lacZ gene in M13mp2 can be scored by
the number of plaques with altered color phenotype (pale blue or clear)
in a specific indicator strain. As seen in Table
I, the R78A HIV-1 RT mutant showed an
8.9-fold reduced rate of mutagenesis than the wild type HIV-1 RT; this
mutation frequency of R78A was similar with that of AMV RT (3).
We have sequenced the entire 361-base pair lacZ
gene from
23 mutant colonies obtained from copying reactions with wild type RT
and 18 mutant colonies obtained with R78A RT. All colonies contained
single mutations within the lacZ target, i.e. 21 base substitutions and 2 frameshifts for WT, and 15 base substitutions and 3 frameshifts for R78A. These data establish that all of the sequenced colonies were authentic mutants substantiating the large decrease in mutation frequency observed for R78A.
Determination of Kd of Two Hi-Fi HIV-1 RT Proteins with a
DNA Template--
Our structural model suggested that the Asp-76 and
Arg-78 residues interact with the template nucleotide. This model was
basically confirmed by a structural study by Huang et al.
(25) with the exception that the Arg-78 residue interacts with the
Asp-76 residue and indirectly with the template nucleotide base pairing
with the incoming dNTP. We tested whether mutations in these Asp-76 and
Arg-78 residues affect the binding affinity of HIV-1 RT to DNA and RNA
templates. We measured the Kd values of wild type,
D76V, and R78A HIV-1 RT proteins to two templates: 1) a 63-mer DNA
template annealed to a 17-mer primer (Fig. 1) and 2) a HIV-1 RT RNA
annealed to the 3305 primer (Fig. 2). The D76V HIV-1 RT mutant is a
hi-fi RT mutant that we previously characterized (22). The
Kd value, indicative of binding affinity (28, 29),
for each protein was calculated as described by Carroll et
al. (28). As seen in Table II, the
D76V mutant RT showed 6.7- and 5.6-fold lower Kd
values than wild type RT with DNA and RNA templates, respectively.
Conversely, the R78A mutant showed 7.6- and 6.0-fold higher
Kd values than wild type with DNA and RNA templates.
Tighter binding (lower Kd) of the D76V RT to the
template might be because of the removal of the negatively charged
Asp-76 residue, which interacts with the phosphate backbone of the
template nucleotide base pairing to the incoming dNTP. Low binding
(higher Kd) of the R78A HIV-1 RT mutant to the
template might also be because of the removal of the positively charged
Arg-78 residue, which interacts with the negative charge of Asp-76 that
interacts with the ribose ring of the template nucleotide base pairing
with the incoming dNTP (this study and 25).
Processivity of Asp-76 and Arg-78 HIV-1 RT Mutants with DNA and RNA
Templates--
Because template binding affinity of these two mutants,
R78A and D78V, was altered, we tested these hi-fi HIV-1 RT mutants for
altered processivity. We determined the processivity of the wild type
D76V and R78A HIV-1 RT mutant protein by using two different templates:
poly(rA) annealed to the 20-mer oligo(dT) as a RNA template (Fig.
3A) and single strand M13 DNA
annealed to the 20-mer forward primer (Fig. 3B). For these
experiments we used equal quantities of RT activities for each of the
three enzyme reactions; enzyme activity was standardized in terms of
measured activity during a single round of the primer extension assay.
As seen in the lanes marked "Processivity" (Fig. 3, A
and B), under our reaction conditions wild type HIV-1 RT and
D76V with poly(rA) template and M13 single-stranded DNA template
extended the primer up to 160 and 80 nt, respectively. However, D76V RT
showed a higher portion of largely extended primers (~80-160 nt for
RNA template reactions and 40-80 nt in DNA template reactions) in the
total extended primer than wild type RT. Average sizes of the total extended primers by wild type RT and D76V were approximately 90 and 110 nt in poly(rA) template and 25 and 35 nt in DNA template, suggesting
D76V shows slightly higher processivity. However, R78A showed largely
decreased average sizes of the primer in both RNA (60 nt) and DNA (10 nt). Therefore, mutations at the Arg-78 and Asp-76 residues of HIV-1 RT
altered enzyme processivity. Our assay showed that the processivity of
wild type RT with poly(rA) and M13 DNA templates was lower than
previously reported (30). This discrepancy could be because of the
higher KCl concentration (100 mM) used in our reaction
conditions, which may reduce the processivity of HIV-1 RT as described
by Huber et al. (30). Fig. 3A also shows two
control experiments that confirmed the single round extension reaction
during the processivity measurement. We used a trap to inhibit the
binding of the free RT molecules to the template·primer. This trap
contained heparin and excess molar poly(rA)/oligo(dT). The +Trap
reactions of Fig. 3A show the control reactions that
contained the poly(rA)/oligo(dT) and heparin trap before RT proteins
were added; this completely blocked RT binding to the labeled
template·primer. However, as seen in the
Trap reactions of Fig.
3A, because of multiple rounds of primer extension in the
absence of the trap, the primers were extended more completely than in
the single round extension reactions. These two control experiments
confirmed that the processivity of the three RT proteins was measured
during a single round of extension. Both + and
Trap controls were
also performed with the DNA template, and the same results confirming
the single round of extension were observed (data not shown).

View larger version (128K):
[in this window]
[in a new window]
|
Fig. 3.
Processivity of HIV-1 RT proteins with DNA
and RNA templates. Poly(rA) annealed to a 20-mer oligo(dT)
(A, RNA template) and M13mp18 single strand DNA annealed to
a 20-mer forward primer (B, DNA template) were used in this
assay. DV and RA indicate D76V and R78A HIV-1 RT
mutant proteins, respectively. Processivity: RNA
(A) or DNA T·P (B) was first preincubated with
RT proteins (wild type (WT), D76V, R78A), and then the
extension reactions were initiated by adding trap mixture containing
dNTPs, poly(rA)/oligo(dT), and heparin (see "Experimental
Procedures"). This condition allowed only a single round of primer
extension by RT. +Trap, RNA T·P was first premixed with
the trap mixture, and the extension reactions were initiated by adding
RT proteins. This condition blocked RT binding to the labeled T·P.
Trap, RNA T·P was premixed with RT proteins, and then
the extension reactions were initiated by only dNTPs (without
poly(rA)/oligo(dT) and heparin). This condition allowed multiple rounds
of primer extension by RT proteins. All reactions were analyzed by 10%
denaturing gel electrophoresis. WT, wild type.
|
|
Misincorporation of Wild Type and R78A SIV RT Proteins--
The
Arg-78 residue is conserved between HIV-1 RT and SIV RT. We tested
whether the R78A mutation affects replicational accuracy of SIV RT by
using the misinsertion assay. As seen in Fig.
4, extension reactions with all four
dNTPs (Fig. 4A) or only three dNTPs (Fig. 4, B
and C) were performed with two different protein concentrations (4× and 1×) of two SIV RT proteins. As seen in Fig. 4,
B (
TTP) and C (
dCTP), the SIV RT R78A mutant
protein showed much less extended primer in the reactions with only
three dNTPs than wild type SIV RT, suggesting that the R78A SIV RT
mutant has a reduced misincorporation capability as observed for the HIV-1 in RT R78A and D78V mutants. We also performed misinsertion assays with RNA template encoding the HIV-1 sequence, and in this assay, the R78A SIV RT mutant also showed reduced misincorporation capability compared with the wild type SIV RT protein (data not shown).
These data suggested that the SIV RT R78A mutant, like its HIV-1
counterpart, is a hi-fi mutant.

View larger version (102K):
[in this window]
[in a new window]
|
Fig. 4.
Misinsertion assay with wild type and R78A
SIV RT mutants. The 32P-labeled 17-mer primer
(arrow) annealed to a 63-mer DNA template (5 nM)
was extended by two different concentrations (4× and 1×) of wild type
and R78A SIV RT proteins at 37 °C for 5 min (see A for
the reactions with all four dNTPs). The extension reactions were
performed in the presence of all four (A) or only three
complementary dNTPs. B, minus TTP; C, minus dCTP.
The extension reactions were analyzed by 14% denaturing gel
electrophoresis. WT, wild type; C, unextended
primer.
|
|
Modeling Interactions of Arg-78 and Asp-76 Residues with Template
Nucleotides--
Fig. 5 shows the
structure for the region of HIV-1 RT interacting with the template
(25). We previously thought that HIV-1 RT Asp-76 interacted with the
template nucleotide base pairing to the incoming dNTPs and that Arg-78
directly interacted with the 5'-phosphate of the template nucleotide
base pairing to the 3'-end of the primer. Our model had been
constructed from 1hin.pdb (31) and 1hmi.pdb (32) with the former being
a structure of an inhibited HIV-RT without bound nucleotides and the
latter of HIV-RT with bound DNA but containing only coordinates for
C
atoms and phosphate backbone atoms. In this model, both Asp-76 and
Arg-78 extended toward the template; Asp-76 extended toward the
nucleotide that would bind to the incoming dNTP, and Arg-78 extended
toward the adjacent nucleotide in the template. The recent 3.2 Å structure (25) of HIV-RT with template, primer, and an incoming bound
nucleotide shows that in fact Asp-76 and Arg-78 are hydrogen bonded to
each other, and Asp-76 forms close contacts with the ribose ring of the
nucleotide bound to the incoming nucleotide. It is entirely possible
that the interactions we proposed earlier could happen at a stage prior
to the state represented by this most recent x-ray structure.

View larger version (121K):
[in this window]
[in a new window]
|
Fig. 5.
Structure of the interactions of residues
Arg-78 and Asp-76 of HIV-1 RT with template nucleotides. This
figure shows the local structure of HIV-1 RT protein complexed with
template, primer, and incoming nucleotides (25) using coordinate set
1rtd.pdb from the Protein Data Bank (38). The single-stranded part of
the template is shown in yellow, the double-stranded part of
the template annealed to the primer (purple) is light
blue, and the nucleotide base paired to the incoming nucleotide is
blue-green. The finger domain containing Arg-78
(blue) and Asp-76 (red) is shown as a dark
gray space and line representation, and the palm domain containing
Glu-89 and Met-184 is a light gray space representation. The
side chains of Arg-78 and Asp-76 face toward each other. Asp-76
contacts the ribose ring of the template nucleotide base pairing to the
incoming dNTPs, whereas Arg-78 interacts with Asp-76 and indirectly to
that template nucleotide. This figure was made using the programs
Molscript (39) and Raster3D (33).
|
|
Our site-directed mutagenesis studies on Asp-76 (22) and Arg-78
residues (this study) suggest that the charges in these two residues
are important in their roles in fidelity and interactions (Kd and processivity) with the template. Two other
positions of HIV-1 RT, Met-184 and Glu-89, showing both drug resistance and increased fidelity, are also shown in this picture. Glu-89 interacts with the penultimate template nucleotide, whereas Met-184 at
the conserved YMDD catalytic site is near to the dNTP binding site.
Because of the difference in the structural locations of these fidelity
mutations, it is plausible that mutations at the residues interacting
with the template nucleotides (Asp-76, Arg-78, and Glu-89) might affect
the replicational accuracy differently from mutations at Met-184 of
HIV-1 RT (see "Discussion").
 |
DISCUSSION |
Analysis of HIV-1 RT mutants with altered replicational accuracy
is a key element in pinpointing molecular mechanisms of inaccurate DNA
synthesis by HIV-1 RT. It is likely that HIV-1 RT mutants with largely
altered fidelity might not be selected from infected hosts if RT is
responsible for viral variation. Large alterations of HIV-1 RT fidelity
could restrain the capability of HIV-1 to evolve and escape. Therefore,
to obtain HIV-1 RT mutants with altered fidelity, we have employed both
genetic and biochemical approaches. First, active HIV-1 RT mutants were
isolated using a bacterial genetic system that selects for active
enzymes generated from a randomly mutated pool of active HIV-1 RT
mutants. Second, a misinsertion assay measuring the mutation synthesis
capability of HIV-1 RT proteins was used to identify novel HIV-1 RT
mutants with altered fidelity. These selected enzyme mutants were then further analyzed for their fidelity by using both the M13mp2
lacZ forward mutation assay and kinetic measurements for the
misincorporation rate (fmis). Previously we
isolated an active D76V HIV-1 RT mutant with enhanced accuracy (22).
This D76V HIV-1 RT mutant showed approximately 9-fold higher fidelity
than wild type HIV-1 RT, and our earlier modeling studies suggested
that the Asp-76 residue interacts with the template nucleotide base
pairing with the incoming dNTP (Fig. 5). Based on this information, we
hypothesized that, in wild type HIV-1 RT, the interaction of the Asp-76
residue with this template nucleotide occasionally interferes with base
pairing of the template nucleotide to the incoming dNTP, resulting in frequent mutation synthesis. This model also suggested that the Arg-78
residue directly interacts with 5'-phosphate of the template nucleotide
base pairing the primer nucleotide at the 3'-end of the primer, which
is the same as the 3'-phosphate of the template nucleotide both base
pairing to the incoming dNTP and interacting with the Asp-76 residue.
In this study, we tested whether alterations in the proposed
interaction between the Arg-78 residue of HIV-1 RT and the template nucleotide base pairing to the 3'-end primer nucleotide also affect replicational accuracy. As seen in misinsertion assays (Figs. 1 and 2)
and the M13mp2 lacZ forward mutation assay (Table I), the
R78A HIV-1 RT mutant protein showed 8.9 times higher fidelity, confirming our prediction that the Arg-78 residue of HIV-1 RT is
important in enzymatic infidelity. To confirm the interactions of both
the Arg-78 residue and the Asp-76 residue with the template nucleotides, Kd values of three RT proteins, wild
type, R78A, and D76V, with DNA and RNA templates were determined. The D76V mutant protein showed lower Kd than the wild
type enzyme, whereas the R78A protein showed a much higher
Kd than wild type for both templates. Tighter
binding of D76V to the template might be because of the removal of the
negatively charged Asp-76 residue that in turn allows Arg-78 to
interact with the phosphate backbone of the template nucleotide. In
contrast a previously described (E89G) hi-fi mutant affecting the
interaction of the penultimate nucleotide of the double strand part of
the template showed the same level of Kd for RNA
templates as did wild type RT (26). Instead, the E89G mutant showed
reduced koff compared with wild type. It is
therefore likely that the Asp-76 and Glu-89 residues may have different
roles in template binding because they interact with different template
nucleotides. In contrast to the D76V mutant, the lower binding affinity
of R78A to the template might result from the removal of the positive charge of the Arg-78 residue that interacts with the negative charge of
Asp-76, which interacts with the template nucleotide.
The R78A hi-fi mutant showed largely decreased processivity in both RNA
and DNA templates, suggesting that removal of the interaction between
the Arg-78 and Asp-76 residues influences the ability to extend the
primer as well as initial binding (Kd) to the
template. Many primer grip HIV-1 RT mutants have shown both a decreased
processivity and an increased frameshift mutation rate but not a point
mutation rate (5, 19-21). It was proposed that the increased
frameshift mutation rate of these primer grip mutants might result from
the increased mutation synthesis mediated by a T·P slippage
mechanism. It is plausible that the decreased processivity by the R78A
mutation might not affect T·P slippage-mediated mutation synthesis.
In other words, the R78A mutation and primer grip mutations may
decrease processivity by different mechanisms, as suggested by the
structural models of HIV-1 RT (20, 21). M184V and M184I 3TC resistant
mutant RT proteins with increased fidelity also have processivity
defects (34), and it was proposed that the imbalance of dNTP pools be a
factor for the processivity defect of Met-184 drug-resistant mutants
(34, 35).
The potential physiologic relevance of the R78A substitution can be
inferred from our misincorporation data and the fact that the G
A
transitions in the plus strand are believed to be the most common and
important mutation synthesized by HIV in vivo (36, 37).
These transitions can arise from G:T mispairs formed and extended
during synthesis on an RNA template or C:A mispairs formed and extended
during synthesis on a DNA template. The R78A mutant exhibited reduced
misincorporation in the "minus C" reactions with an RNA template
(Fig. 2) and the "minus G" reaction with the DNA template (Fig. 1),
suggesting that it may catalyze fewer of the mutations believed to be
most crucial to HIV physiology.
Presumably, wild type HIV-1 RT evolved to use both residues Asp-76 and
Arg-78 of HIV-1 RT to create an active site structure that favors
occasional mutation synthesis. We reason that Arg-78 has been retained
during HIV-1 RT evolution because it supports both catalytic activity
and viral mutability. It is apparent that HIV-1 has evolved to be
hypermutable, presumably because hypermutability promotes evasion of
antiviral pressures. If an amino acid affects both catalytic activity
and mutability, as does Arg-78, the outcome of natural selection must,
perforce, reflect the contribution of that amino acid to both
phenotypes. The misinsertion assays with SIV RT proteins suggest that
SIV, like HIV-1 RT, might also employ the Arg-78 residue to create a
mutagenic DNA polymerase.
Many residues of HIV-1 RT interacting with the template near the DNA
polymerase active site of HIV-1 RT have been identified (25). They are
the Asp-76, Arg-78, Lys-154, Gly-152, and Glu-89 residues. Among these
residues, mutations in Asp-76, Arg-78, and Glu-89 affect both accuracy
and interactions with the templates. We recently tested the fidelity
and processivity of the HIV-1 RT K154 mutants, and we found that,
unlike the Asp-76, R78A, and Glu-89 mutants, Lys-154 mutants affect
only processivity and not fidelity, suggesting that not all residues
involved in template interactions contribute to HIV-1 RT infidelity
(data not shown). Therefore, three RT residues of HIV-1 RT (Asp-76,
Arg-78, and Glu-89), which are involved in both replicational accuracy
and processivity, provide HIV-1 RT with a mechanism that allows the virus to sustain efficient mutation synthesis required for viral evolution and escape.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Lawrence A. Loeb, Robert A. Bambara, Ann Blank, and Stephen Dewhurst and Peter Gerondelis for
critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant R29-GM55500 (to B. K.). Structure modeling was supported by NIEHS National Institutes of Health Grant P30-ES07033 (to E. T. A.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Box 672, 601 Elmwood Ave., Dept. of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642. Tel.: (716) 275-6916; Fax: (716) 473-9573; E-mail: baek_kim@urmc.rochester.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
HIV-1, human
immunodeficiency virus, type 1;
RT, reverse transcriptase;
AMV, avian
myeloblastosis virus;
PCR, polymerase chain reaction;
T·P, template·primer complex;
p66, 66-kDa RT polypeptide;
p51, 51-kDa RT
polypeptide;
nt, nucleotide(s);
SIV, Simian immunodeficiency
virus.
 |
REFERENCES |
| 1.
|
Coffin, J. M.
(1990)
in
Retroviridae and Their Replication in Virology
(Fields, B. N.
, Knipe, D. M.
, Chanock, R. M.
, Howley, P. M.
, Melnick, J. L.
, Monath, T. P.
, Roizman, B.
, and Straus, S. E., eds)
, pp. 1437-1500, Raven Press Ltd., New York
|
| 2.
|
Coffin, J. M.
(1995)
Science
267,
483-489
|
| 3.
|
Roberts, J. D.,
Preston, B. D.,
Johnston, L. A.,
Soni, A.,
Loeb, L. A.,
and Kunkel, T. A.
(1989)
Mol. Cell. Biol.
9,
469-476[Abstract/Free Full Text]
|
| 4.
|
Williams, K. J.,
and Loeb, L. A.
(1992)
Curr. Top. Microbiol. Immunol.
176,
165-180[Medline]
[Order article via Infotrieve]
|
| 5.
|
Bebenek, K.,
Abbotts, J.,
Wilson, S. H.,
and Kunkel, T. A.
(1993)
J. Biol. Chem.
268,
10324-10334[Abstract/Free Full Text]
|
| 6.
|
Preston, B. D.,
and Dougherty, J. P.
(1996)
Trends. Microbiol.
4,
16-21[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Preston, B. D.,
Poiesz, B. J.,
and Loeb, L. A.
(1988)
Science
242,
1168-1171[Abstract/Free Full Text]
|
| 8.
|
Coffin, J. M.
(1990)
in
Applied Virology Research, Virus Variation and Epidemiology
(Kurstak, E.
, Marusyk, F. A.
, Murphy, M. H. V.
, and Van Regenmortel, M., eds), Vol. 2
, pp. 11-33, Plenum Press, New York
|
| 9.
|
Palaniappan, C.,
Wisniewski, M.,
Wu, W.,
Fay, P. J.,
and Bambara, R. A.
(1996)
J. Biol. Chem.
271,
22331-22338[Abstract/Free Full Text]
|
| 10.
|
Wu, W.,
Blumberg, B. M.,
Fay, P. J.,
and Bambara, R. A.
(1995)
J. Biol. Chem.
270,
325-332[Abstract/Free Full Text]
|
| 11.
|
Perelson, A. S.,
Neumann, A. U.,
Markowitz, M.,
Leonard, J. M.,
and Ho, D. D.
(1996)
Science
271,
1582-1586[Abstract]
|
| 12.
|
Joyce, C. M.,
and Steitz, T. A.
(1994)
Annu. Rev. Biochem.
63,
777-822[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Joyce, C. M.,
and Steitz, T. A.
(1995)
J. Bacteriol.
177,
6321-6329[Free Full Text]
|
| 14.
|
Minnick, D. T.,
Bebenek, K.,
Osheroff, W. P.,
Turner, R. M., Jr.,
Astatke, M.,
Liu, L.,
Kunkel, T. A.,
and Joyce, C. M.
(1995)
J. Biol. Chem.
274,
3067-3075[Abstract/Free Full Text]
|
| 15.
|
Wainberg, M. A.,
Drosopoulos, W. C.,
Salomon, H.,
Hsu, M.,
Borkow, G.,
Parniak, M.,
Gu, Z.,
Song, Q.,
Manne, J.,
Islam, S.,
Castriota, G.,
and Prasad, V. R.
(1996)
Science
271,
1282-1285[Abstract]
|
| 16.
|
Pandey, V. N.,
Kaushik, N.,
Rege, N.,
Sarafianos, S. G.,
Yadav, P. N.,
and Modak, M. J.
(1996)
Biochemistry
35,
2168-2179[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Oude Essink, B. B.,
Back, N. K.,
and Berkhout, B.
(1997)
Nucleic Acids Res.
25,
3212-3217[Abstract/Free Full Text]
|
| 18.
|
Drosopoulos, W. C.,
and Prasad, V. R.
(1996)
J. Virol.
70,
4834-4838[Abstract]
|
| 19.
|
Jonckheere, H.,
Witvrouw, M.,
De Clercq, E.,
and Anne, J.
(1998)
AIDS Res. Hum. Retroviruses
14,
249-253[Medline]
[Order article via Infotrieve]
|
| 20.
|
Bebenek, K.,
Beard, W. A.,
Casas-Finet, J. R.,
Kim, H. R.,
Darden, T. A.,
Wilson, S. H.,
and Kunkel, T. A.
(1995)
J. Biol. Chem.
270,
19516-19523[Abstract/Free Full Text]
|
| 21.
|
Beard, W. A.,
Minnick, D. T.,
Wade, C. L.,
Prasad, R.,
Won, R. L.,
Kumar, A.,
Kunkel, T. A.,
and Wilson, S. H.
(1996)
J. Biol. Chem.
271,
12213-12220[Abstract/Free Full Text]
|
| 22.
|
Kim, B.,
Hathaway, T. R.,
and Loeb, L. A.
(1998)
Biochemistry
37,
5831-5839[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Kim, B.,
Hathaway, T. R.,
and Loeb, L. A.
(1996)
J. Biol. Chem
271,
4872-4878[Abstract/Free Full Text]
|
| 24.
|
Kim, B.
(1997)
Methods (Orlando)
12,
318-324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Huang, H.,
Chopra, R.,
Verdine, G. L.,
and Harrison, S. C.
(1998)
Science
282,
1669-1675[Abstract/Free Full Text]
|
| 26.
|
Quan, Y.,
Inouye, P.,
Liang, C.,
Rong, L.,
Gotte, M.,
and Wainberg, M. A.
(1998)
J. Biol. Chem.
273,
21918-21925[Abstract/Free Full Text]
|
| 27.
|
Bebenek, K.,
and Kunkel, T. A.
(1995)
Methods Enzymol.
262,
217-232[Medline]
[Order article via Infotrieve]
|
| 28.
|
Carroll, S. S.,
Cowart, M.,
and Benkovic, S. J.
(1991)
Biochemistry
30,
804-813[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Patel, P. H.,
Jacobo-Molina, A.,
Ding, J.,
Tantillo, C.,
Clark, A. D., Jr.,
Raag, R.,
Nanni, R. G.,
Hughes, S. H.,
and Arnold, E.
(1995)
Biochemistry
34,
5351-5363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Huber, H. E.,
McCoy, J. M.,
Seehra, J. S.,
and Richardson, C. C.
(1989)
J. Biol. Chem.
264,
4669-4678[Abstract/Free Full Text]
|
| 31.
|
Ding, J.,
Das, K.,
Tantillo, C.,
Zhang, W.,
Clark, A. D., Jr.,
Jessen, S.,
Lu, X.,
Hsiou, Y.,
Jacoba-Molina, A.,
Andries, K.,
Pauwels, R.,
Moereels, H.,
Koymans, L.,
Janssen, P. A, J.,
Smith, R. H., Jr.,
Koepke, M. K.,
Michejda, C. J.,
Hughes, S. H.,
and Arnold, E.
(1995)
Structure
3,
365-379[Medline]
[Order article via Infotrieve]
|
| 32.
|
Jacoba-Molina, A.,
Ding, J.,
Nanni, R. G.,
Clark, A. D., Jr.,
Lu, X.,
Tantillo, C.,
Williams, R. L.,
Kamer, G.,
Ferris, A. L.,
Clark, P.,
Hizi, A.,
Hughes, S. H.,
and Arnold, E.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
6320-6324[Abstract/Free Full Text]
|
| 33.
|
Merritt, E. A.,
and Bacon, D. J.
(1997)
Methods Enzymol.
277,
505-524[Medline]
[Order article via Infotrieve]
|
| 34.
|
Back, N. K.,
and Berkhout, B.
(1997)
Antimicrob. Agents Chemother.
41,
2484-2491[Abstract]
|
| 35.
|
Vartanian, J. P.,
Plikat, U.,
Henry, M.,
Mahieux, R.,
Guillemot, L.,
Meyerhans, A.,
and Wain-Hobson, S.
(1997)
J. Mol. Biol.
270,
139-151[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Varatnian, J. P.,
Meyerhans, A.,
Asjo, B.,
and Wain-Hobson, S.
(1991)
J. Virol.
65,
1779-1789[Abstract/Free Full Text]
|
| 37.
|
Fitzgibbon, J. E.,
Mazar, S.,
and Dubin, D. T.
(1993)
AIDS Res. Hum. Retroviruses
9,
833-838[Medline]
[Order article via Infotrieve]
|
| 38.
|
Bernstein, F. C.,
Koetzle, T. F.,
Williams, G. J. B.,
Meyer, E. F.,
Bruce, M. D.,
Rodgers, J. R.,
Kennard, O.,
Shimanouchi, T.,
and Tasmui, M.
(1977)
J. Mol. Biol.
112,
535-542[Medline]
[Order article via Infotrieve]
|
| 39.
|
Kraulis, P.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. A. Howell, C. M. Kondratick, and M. T. Washington
Substitution of a residue contacting the triphosphate moiety of the incoming nucleotide increases the fidelity of yeast DNA polymerase {zeta}
Nucleic Acids Res.,
March 1, 2008;
36(5):
1731 - 1740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ferrer-Orta, A. Arias, R. Perez-Luque, C. Escarmis, E. Domingo, and N. Verdaguer
Sequential structures provide insights into the fidelity of RNA replication
PNAS,
May 29, 2007;
104(22):
9463 - 9468.
[Abstract]
[Full Text]
[PDF]
|
 |
|